Cardiac Resynchronization in Chronic Heart Failure
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Previous studies have suggested that cardiac resynchronization achieved through atrial-synchronized biventricular pacing produces clinical benefits in patients with heart failure who have an intraventricular conduction delay. We conducted a double-blind trial to evaluate this therapeutic approach. METHODS: Four hundred fifty-three patients with moderate-to-severe symptoms of heart failure associated with an ejection fraction of 35 percent or less and a QRS interval of 130 msec or more were randomly assigned to a cardiac-resynchronization group (228 patients) or to a control group (225 patients) for six months, while conventional therapy for heart failure was maintained. The primary end points were the New York Heart Association functional class, quality of life, and the distance walked in six minutes. RESULTS: As compared with the control group, patients assigned to cardiac resynchronization experienced an improvement in the distance walked in six minutes (+39 vs. +10 m, P=0.005), functional class (P<0.001), quality of life (-18.0 vs. -9.0 points, P= 0.001), time on the treadmill during exercise testing (+81 vs. +19 sec, P=0.001), and ejection fraction (+4.6 percent vs. -0.2 percent, P<0.001). In addition, fewer patients in the group assigned to cardiac resynchronization than control patients required hospitalization (8 percent vs. 15 percent) or intravenous medications (7 percent vs. 15 percent) for the treatment of heart failure (P<0.05 for both comparisons). Implantation of the device was unsuccessful in 8 percent of patients and was complicated by refractory hypotension, bradycardia, or asystole in four patients (two of whom died) and by perforation of the coronary sinus requiring pericardiocentesis in two others. CONCLUSIONS: Cardiac resynchronization results in significant clinical improvement in patients who have moderate-to-severe heart failure and an intraventricular conduction delay.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While clinical improvements are generally achieved, six-month nonresponder rates have been reported to be as high as 32–43%11,13, which is partially attributed to anatomic constraints of lead positioning14.”
From Synchronized Biventricular Heart Pacing in a Closed-chest Porcine Model based on Wirelessly Powered Leadless Pacemakers (2020) · cites this paper as [11]
In the citing paper
“About 30% of patients with impaired cardiac function have ventricular dyssynchrony and seek cardiac resynchronization therapy (CRT).”
From Synchronized Biventricular Heart Pacing in a Closed-chest Porcine Model based on Wirelessly Powered Leadless Pacemakers (2020) · cites this paper as [11]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Cazeau, S., Leclercq, C., Lavergne, T., Walker, S., Varma, C., Linde, C., Garrigue, S., Kappenberger, L., Haywood, G. A., Santini, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441202 · Cited by 2,751
Pitt, B., Poole-Wilson, P. A., Segal, R., Martinez, F. A., Dickstein, K., Camm, A. J., Konstam, M. A., Riegger, G., Klinger, G. H., Neaton, J., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02213-3 · Cited by 1,961
Pitt, B., Segal, R., Martinez, F. A., Meurers, G., Cowley, A. J., Thomas, I., Deedwania, P. C., Ney, D. E., Snavely, D. B., & Chang, P. I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01187-2 · Cited by 1,665
Aaronson, K. D., Schwartz, J. S., Chen, T.-M., Wong, K.-L., Goin, J. E., & Mancini, D. M. (1997) · Circulation · doi:10.1161/01.cir.95.12.2660 · Cited by 1,188
Auricchio, A., Stellbrink, C., Block, M., Sack, S., Vogt, J., Bakker, P., Klein, H., Kramer, A., Ding, J., Salo, R., et al. (1999) · Circulation · doi:10.1161/01.cir.99.23.2993 · Cited by 1,152
Kass, D. A., Chen, C.-H., Curry, C., Talbot, M., Berger, R., Fetics, B., & Nevo, E. (1999) · Circulation · doi:10.1161/01.cir.99.12.1567 · Cited by 972
Packer, M., Gheorghiade, M., Young, J. B., Costantini, P. J., Adams, K. F., Cody, R. J., Smith, L. K., Van Voorhees, L., Gourley, L. A., & Jolly, M. K. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307013290101 · Cited by 827
Self-citationPacker, M., Colucci, W. S., Sackner-Bernstein, J. D., Liang, C.-S., Goldscher, D. A., Freeman, I., Kukin, M. L., Kinhal, V., Udelson, J. E., Klapholz, M., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2793 · Cited by 613
Self-citation
Research works printed but not linked: 4
- Brophy JM, 1994, Can J Cardiol, 10, 543
- Guyatt GH, 1985, Can Med Assoc J, 132, 919
- Naughton JP, Maider R. Methods of exercise testing. In: Naughton JP, Hellerstein HR, eds. Exercise testing and exercise training in coronary artery disease. New York: Academic Press, 1973:79-91.
- Rector RS, 1987, Heart Fail, 3, 198
Cited by
Items 501–600 of 1,008
In vitro and in vivo assessment of heart-homing porous silicon nanoparticles
Ferreira, M. P. A., Ranjan, S. K., Correia, A. M. R., Mäkilä, E. M., Kinnunen, S. M., Zhang, H., Shahbazi, M., Almeida, P. V., Salonen, J., Ruskoaho, H. J., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.03.046 · Cited by 102
Trimble, M. A., Borges‐Neto, S., Smalheiser, S. A., Chen, J., Honeycutt, E. F., Shaw, L. K., Heo, J., Pagnanelli, R., Tauxe, E. L., Garcia, E. V., et al. (2007) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2007.01.041 · Cited by 94
2013 ESC GUIDELINES ON CARDIAC PACING AND CARDIAC RESYNCHRONIZATION THERAPY
Brignole, M., Auricchio, A., Barón‐Esquivias, G., Bordachar, P., Boriani, G., Breithardt, O. A., Cleland, J. G. F., Deharo, J., Delgado, V., Elliot, P. M., et al. (2014) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2014-4-5-63 · Cited by 95
Marin‐Neto, J. A., Rassi, A., de Oliveira, G. M. M., Correia, L. C. L., Ramos, A. N., Luquetti, A. O., Hasslocher‐Moreno, A. M., de Sousa, A. S., de Paola, Â. A. V., Sousa, A. C. S., et al. (2023) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20230269 · Cited by 166
Management of chronic heart failure
Cowie, M., & Zaphiriou, A. (2002) · BMJ · doi:10.1136/bmj.325.7361.422 · Cited by 100
Kuschyk, J., Roeger, S., Schneider, R., Streitner, F., Stach, K., Rudic, B., Weiß, C., Schimpf, R., Papavasilliu, T., Rousso, B., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.12.178 · Cited by 93
Cardiac resynchronization therapy in congenital heart disease
Khairy, P., Fournier, A., Thibault, B., Dubuc, M., Thérien, J., & VOBECKY, S. J. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.06.065 · Cited by 93
“CRT may improve quality of life, New York Heart Association (NYHA) functional class, exercise capacity, and left ventricular systolic function [1–6].”
BackgroundCannesson, M. P., Tanabe, M., Suffoletto, M. S., McNamara, D. M., Madan, S., Lacomis, J. M., & Gorcsan, J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.045 · Cited by 93
Tanaka, H., Hara, H., ADELSTEIN, E. C., SCHWARTZMAN, D. S., Saba, S., & Gorcsan, J. (2010) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2009.12.014 · Cited by 96
Altman, R., Parks, K. A., Schlett, C. L., Orencole, M. P., Park, M.-Y., Truong, Q. A., Deeprasertkul, P., Moore, S. A., Barrett, C. D., Lewis, G. D., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs107 · Cited by 92
Zanon, F., Baracca, E., Pastore, G., Fraccaro, C., Roncon, L., Aggio, S., Noventa, F., Mazza, A., & Prinzen, F. W. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000850 · Cited by 92
Selecting Patients for Cardiac Resynchronization Therapy
Hawkins, N. M., Petrie, M. C., Burgess, M. I., & McMurray, J. J. V. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.062 · Cited by 92
Patwala, A., Woods, P. R., Sharp, L. K., Goldspink, D. F., Tan, L. B., & Wright, D. J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.063 · Cited by 92
Boriani, G., Kranig, W., Donal, E., Calò, L., Casella, M., Delarche, N., Lozano, I. F., Ansalone, G., Biffi, M., Boulogne, E., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.03.008 · Cited by 92
Cardiac resynchronization therapy: “Nonresponders” and “hyperresponders”
Castellant, P., Fatemi, M., Valls-Bertault, V., ETIENNE, Y., & Blanc, J. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.09.023 · Cited by 92
Circulating miRNA-21 is a promising biomarker for heart failure
Zhang, J., Xing, Q., Zhou, X., Li, J., Li, Y., Zhang, L., Zhou, Q., & Tang, B. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7575 · Cited by 97
Ferreira, A. M., Adragão, P., Cavaco, D., Candeias, R., Morgado, F. B., Santos, K. R., Santos, E., & Silva, J. A. (2008) · EP Europace · doi:10.1093/europace/eun135 · Cited by 91
Advances in Echocardiographic Imaging in Heart Failure With Reduced and Preserved Ejection Fraction
Omar, A. M. S., Bansal, M., & Sengupta, P. P. (2016) · Circulation Research · doi:10.1161/circresaha.116.309128 · Cited by 103
Salukhe, T. V., Francis, D. P., & Sutton, R. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00585-5 · Cited by 91
Current State of Pediatric Heart Failure
Das, B. B. (2018) · Children · doi:10.3390/children5070088 · Cited by 89
Rate‐Dependent AV Delay Optimization in Cardiac Resynchronization Therapy
Scharf, C., Li, P., Muntwyler, J., Chugh, A., Oral, H., Pelosi, F., Morady, F., & Armstrong, W. F. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.40054.x · Cited by 89
Fröhlich, G., Steffel, J., Hürlimann, D., Enseleit, F., Lüscher, T. F., Ruschitzka, F. T., Abraham, W. T., & Holzmeister, J. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq065 · Cited by 96
Self-citationAnderson, L. J., Miyazaki, C., Sutherland, G. R., & Oh, J. K. (2008) · Circulation · doi:10.1161/circulationaha.107.721332 · Cited by 89
Improvement in Cheyne-Stokes respiration following cardiac resynchronisation therapy
Gabor, J. Y., Newman, D. A., Barnard-Roberts, V., Korley, V., Mangat, I., Dorian, P., & Hanly, P. J. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00093904 · Cited by 89
Dong, K., Shen, W.-K., Powell, B. D., Dong, Y.-X., Rea, R. F., Friedman, P. A., Hodge, D. O., Wiste, H. J., Webster, T. L., Hayes, D. L., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.02.011 · Cited by 95
Self-citationvan Geldorp, I. E., Vernooy, K., Delhaas, T., Prins, M. H., Crijns, H. J., Prinzen, F. W., & Dijkman, B. (2010) · Europace · doi:10.1093/europace/eup378 · Cited by 88
Butter, C., Wellnhofer, E., Schlegl, M., Winbeck, G., Fleck, E., & Sabbah, H. N. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.11.004 · Cited by 88
“Although the changes are somewhat larger than observed in the present study with CCM therapy, preliminary findings indicate that LV ejection fraction increases by about 5% with chronic CCM,(18,19) which compares favorably with the reported effects of chronic treatment with resynchronization therapy.(5) The results see…”
Effects of Gender on Peak Oxygen Consumption and the Timing of Cardiac Transplantation
Elmariah, S., Goldberg, L. R., Allen, M. T., & Kao, A. C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.089 · Cited by 87
Marco, T. D., Wolfel, E. E., Feldman, A. M., Lowes, B. D., Higginbotham, M. B., Ghali, J. K., Wagoner, L. E., Kirlin, P. C., Kennett, J. D., Goel, S., et al. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.08.003 · Cited by 87
A unique method by which to quantitate synchrony with equilibrium radionuclide angiography
O’Connell, J. W., Schreck, C., Moles, M., Badwar, N., DeMarco, T., Olgin, J. E., Lee, B. K., Tseng, Z. H., Kumar, U., & Botvinick, E. H. (2005) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2005.05.006 · Cited by 87
Mao, S., Shinbane, J. S., Girsky, M. J., Child, J., Carson, S., Oudiz, R. J., & Budoff, M. J. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.09.050 · Cited by 87
Postero‐Lateral Scar Tissue Resulting in Non‐Response to Cardiac Resynchronization Therapy
Bleeker, G. B., Schalij, M. J., van der Wall, E. E., & Bax, J. J. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00499.x · Cited by 87
Long-Term Reverse Remodeling With Cardiac Resynchronization Therapy
Verhaert, D., Grimm, R. A., Puntawangkoon, C., Wolski, K., De, S. K., Wilkoff, B. L., Starling, R. C., Tang, W. H. W., Thomas, J. D., & Popović, Z. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.022 · Cited by 88
Sciagrà, R., Giaccardi, M., Porciani, M. C., Colella, A., Michelucci, A., Pieragnoli, P., Gensini, G., Pupi, A., & Padeletti, L. (2004) · PubMed · Cited by 87
Theuns, D. A. M. J., Schaer, B. A., Soliman, O. I. I., Altmann, D., Sticherling, C., Geleijnse, M. L., Osswald, S., & Jordaens, L. J. L. M. (2010) · EP Europace · doi:10.1093/europace/euq328 · Cited by 86
Sade, L. E., Demir, Ö., Atar, İ., Müderrisoğlu, H., & Özin, B. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.069 · Cited by 86
Long‐Term Variations in Optimal Programming of Cardiac Resynchronization Therapy Devices
O’Donnell, D., Nadurata, V., HAMER, A. W. F., Kertes, P. J., & MOHAMMED, U. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.00070.x · Cited by 86
Jauvert, G., Rousseau-Paziaud, J., Villain, E., Iserin, L., Hidden‐Lucet, F., Ladouceur, M., & Sidi, D. (2008) · EP Europace · doi:10.1093/europace/eun319 · Cited by 86
Linde, C. M., Gold, M. R., Abraham, W. T., & Daubert, J. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.03.002 · Cited by 92
Self-citationBogaard, M. D., Houthuizen, P., Bracke, F. A. L. E., Doevendans, P. A., Prinzen, F. W., Meine, M., & van Gelder, B. M. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr094 · Cited by 85
Wang, Y., Gu, K., Qian, Z., Hou, X., Chen, X., Qiu, Y., Jiang, Z., Zhang, X., Wu, H., Chen, M., et al. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14628 · Cited by 86
GAMMAGE, M. D., LIEBERMAN, R. A., YEE, R., MANOLIS, A. S., COMPTON, S. J., KHAZEN, C., SCHAAF, K., OLESON, K. A., CROSSLEY, G. H., & for the Worldwide SelectSecure Clinical Investigators (2006) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2006.00452.x · Cited by 86
Cardiopulmonary Exercise Testing
Milani, R. V., Lavie, C. J., & Mehra, M. R. (2004) · Circulation · doi:10.1161/01.cir.0000136811.45524.2f · Cited by 85
Bleasdale, R. A., Turner, M., Mumford, C. E., Paul Steendijk, A., Paul, V. E., Tyberg, J. V., Morris‐Thurgood, J., & Frenneaux, M. P. (2004) · Circulation · doi:10.1161/01.cir.0000145169.82004.cf · Cited by 85
Cardiac resynchronization therapy for heart failure: biventricular pacing and beyond
Abraham, W. T. (2002) · Current Opinion in Cardiology · doi:10.1097/00001573-200207000-00004 · Cited by 84
Self-citationGasparini, M., Mantica, M., Galimberti, P., BOCCIOLONE, M., Genovese, L., Mangiavacchi, M., Marchesina, U. L., Faletra, F. F., Klersy, C., COATES, R., et al. (2003) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2003.00009.x · Cited by 84
“6,7 The implantation site was designated on the basis of five separate coronary sinus tributaries (CSTs): (1) anterior (ANT), (2) anterolateral (AL), (3) lateral (LAT), (4) posterolateral (PL), and (5) middle cardiac vein (MCV).”
First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead
Sperzel, J., Dänschel, W., Gutleben, K., Kranig, W., Mortensen, P. B., Connelly, D. T., Trappe, H.-J., Seidl, K.-H., Duray, G. Z., Pieske, B. M., et al. (2011) · EP Europace · doi:10.1093/europace/eur322 · Cited by 84
“7 [1–10] configurations were usable per patient (bipolar: 3.”
BackgroundVentricular Assist Devices: Important Information for Patients and Families
Givertz, M. M. (2011) · Circulation · doi:10.1161/circulationaha.111.018226 · Cited by 103
Varma, N. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.01.379 · Cited by 94
Pazhenkottil, A. P., Buechel, R. R., Husmann, L., Nkoulou, R. N., Wolfrum, M., Ghadri, J. R., Kummer, J., Herzog, B. A., & Kaufmann, P. A. (2010) · Heart · doi:10.1136/hrt.2010.201566 · Cited by 84
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure
Heidenreich, P. A., Fonarow, G. C., Breathett, K. K., Jurgens, C. Y., Pisani, B., Pozehl, B., Spertus, J. A., Taylor, K. G., Thibodeau, J. T., Yancy, C. W., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.07.023 · Cited by 86
Kerckhoffs, R. C. P., McCulloch, A. D., Omens, J. H., & Mulligan, L. J. (2008) · Medical Image Analysis · doi:10.1016/j.media.2008.06.013 · Cited by 83
“CRT trials have demonstrated improved quality of life in most patients (Bax et al., 2005), but that they also have shown that approximately 30% of patients do not respond to CRT ( Abraham et al., 2002; Auricchio et al., 2002).”
BackgroundClinical Management and Prevention of Sudden Cardiac Death
Yousuf, O. K., Chrispin, J., Tomaselli, G. F., & Berger, R. D. (2015) · Circulation Research · doi:10.1161/circresaha.116.304555 · Cited by 92
Beela, A. S., Ünlü, S., Duchenne, J., Ciarka, A., Daraban, A. M., Kotrč, M., Aarones, M., Szulik, M., Winter, S., Pěnička, M., et al. (2018) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jey029 · Cited by 88
Rinaldi, C. A., Leclercq, C., Kranig, W., Kacet, S., Betts, T. R., Bordachar, P., Gutleben, K. J., Shetty, A., Donal, E., Keel, A. J., et al. (2014) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-014-9891-1 · Cited by 82
Dyssynchrony, Contractile Function, and Response to Cardiac Resynchronization Therapy
Knappe, D., Pouleur, A., Shah, A. M., Cheng, S. C., Uno, H., Hall, W. J., Bourgoun, M., Foster, E., Zaręba, W., Goldenberg, I., et al. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.962902 · Cited by 82
Mechanistic Evaluation of Echocardiographic Dyssynchrony Indices
Lumens, J., Leenders, G. E. H., Cramer, M. J., Boeck, B. W. L. D., Doevendans, P. A., Prinzen, F. W., & Delhaas, T. (2012) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.112.973446 · Cited by 82
“ure, wide QRS complex, and decreased left ventricular (LV) ejection fraction (LVEF <35%).(1,2) Despite the demonstrated”
BackgroundTäger, T., Hanholz, W., Cebola, R., Fröhlich, H., Franke, J., Doesch, A. O., Katus, H. A., Wians, F. H., & Frankenstein, L. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.06.035 · Cited by 90
Reverse remodelling in heart failure with cardiac resynchronisation therapy
Sutton, M. S.-J., & Keane, M. G. (2006) · Heart · doi:10.1136/hrt.2005.067967 · Cited by 82
Influence of left bundle branch block on long-term mortality in a population with heart failure
Tabrizi, F. N., Englund, A., Rosenqvist, M., Wallentin, L. C., & Stenestrand, U. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm262 · Cited by 82
Cardiovascular Molecular Imaging
Wu, J. C., Bengel, F. M., & Gambhir, S. S. (2007) · Radiology · doi:10.1148/radiol.2442060136 · Cited by 82
Dyssynchrony Indices To Predict Response to Cardiac Resynchronization Therapy
Miyazaki, C., Redfield, M. M., Powell, B. D., Lin, G., Herges, R. M., Hodge, D. O., Olson, L. J., Hayes, D. L., Espinosa, R. E., Rea, R. F., et al. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.848085 · Cited by 81
Self-citationCardiac device infections are associated with a significant mortality risk
de Bie, M. K., van Rees, J. B., Thijssen, J., Borleffs, C. J. W., Trines, S. A. I. P., Cannegieter, S. C., Schalij, M. J., & van Erven, L. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.10.034 · Cited by 82
D’Ascia, C., Cittadini, A., Monti, M. G., Riccio, G., & Saccà, L. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi579 · Cited by 81
Altisent, O. A., Puri, R., Regueiro, A., Chamandi, C., Gabella, T. R., Trigo, M. D., Campelo‐Parada, F., Couture, T., Marsal, J. R., Côté, M., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026349 · Cited by 83
Baseline Characteristics of Patients Recruited Into the CARE-HF Study
Cleland, J. G. F., Daubert, J., Erdmann, E., Freemantle, N., Gras, D., KAPPENBERGER, L. J., Klein, W. W., & Tavazzi, L. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.01.010 · Cited by 81
Cardiac resynchronization therapy: caveat medicus!
Mehra, M. R., & Greenberg, B. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.050 · Cited by 81
“The observed placebo esponse to CRT varies between 38% to nearly 50% in arious trials, whereas the placebo-subtracted improvement n NYHA functional capacity (by 1 functional class) is in he realm of 15% to 30% (5,6).”
BackgroundNytrøen, K., Rolid, K., Andreassen, A. K., Yardley, M., Gude, E., Dahle, D. O., Bjørkelund, E., Relbo Authen, A., Grov, I., Philip Wigh, J., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036747 · Cited by 80
Indications for Cardiac Resynchronization Therapy
Normand, C., Linde, C. M., Singh, J. P., & Dickstein, K. (2018) · JACC Heart Failure · doi:10.1016/j.jchf.2018.01.022 · Cited by 80
Cardiac Resynchronization Therapy in Patients With Minimal Heart Failure
Adabağ, S., Roukoz, H., Anand, I. S., & Moss, A. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.022 · Cited by 80
Left Ventricular Endocardial Stimulation for Severe Heart Failure
Bordachar, P., Derval, N., Ploux, S., Garrigue, S., Ritter, P., Haı̈ssaguerre, M., & Jaı̈s, P. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.038 · Cited by 80
Marsan, N. A., Henneman, M. M., Chen, J., Ypenburg, C., Dibbets, P., Ghio, S., Bleeker, G. B., Stokkel, M. P. M., van der Wall, E. E., Tavazzi, L., et al. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0539-6 · Cited by 80
“(NYHA) functional class III or IV, left ventricular ejection fraction (LVEF)<35%, and QRS duration>120 ms] [2].”
BackgroundGoda, A., Lund, L. H., & MANCINI, D. M. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.09.007 · Cited by 80
Steffel, J., Robertson, M., Singh, J. P., Abraham, W. T., Bax, J. J., Borer, J. S., Dickstein, K., Ford, I., Gorcsan, J., Gras, D., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv242 · Cited by 80
Self-citationConraads, V. M., Vanderheyden, M., Paelinck, B. P., Verstreken, S., Blankoff, I., Miljoen, H., SUTTER, J. D., & Beckers, P. J. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32801164b3 · Cited by 80
Onishi, T., Onishi, T., Marek, J. J., Ahmed, M., Haberman, S. C., Oyenuga, O. A., ADELSTEIN, E. C., SCHWARTZMAN, D. S., Saba, S., & Gorcsan, J. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000112 · Cited by 80
Pathophysiology of congestive heart failure.
Francis, G. S., & Tang, W. H. W. (2003) · PubMed · Cited by 103
Bordachar, P., Garrigue, S., Lafitte, S., Reuter, S., Jaı̈s, P., Haı̈ssaguerre, M., & Clémenty, J. (2003) · Heart · doi:10.1136/heart.89.12.1401 · Cited by 80
Dyssynchrony and the Risk of Ventricular Arrhythmias
Kutyifa, V., Pouleur, A., Knappe, D., Al‐Ahmad, A., Gibiński, M., Wang, P. J., McNitt, S. A., Merkely, B. P., Goldenberg, I., Solomon, S. D., et al. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.12.008 · Cited by 79
Kandala, J., Upadhyay, G. A., Altman, R., Parks, K. A., Orencole, M. P., Mela, T., Heist, E. K., & Singh, J. P. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht123 · Cited by 79
“Cardiac resynchronization therapy improves morbidity, mortality, and reverse remodelling in medically refractory, congestive heart failure patients.(1) –5 Several studies have identified multiple determinants of response to CRT of which QRS duration and morphology(6) along with LV lead location(7) have been noted to b…”
BackgroundZanon, F., Marcantoni, L., Baracca, E., Pastore, G., Lanza, D., Fraccaro, C., Picariello, C., Conte, L., Aggio, S., Roncon, L., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.05.015 · Cited by 79
he, S. T., Wu, J., Li, S.-H., Wang, L., Sun, Y., Xie, J., Ramnath, D., Weisel, R. D., Yau, T. M., Sung, H., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120285 · Cited by 81
Curtis, A. B., Ellenbogen, K. A., Hammill, S. C., Hayes, D. L., REYNOLDS, D. W., Wilber, D. J., & CAIN, M. E. (2004) · Heart Rhythm · doi:10.1016/j.hrthm.2004.08.003 · Cited by 79
Self-citationYU, C., FUNG, J. W., CHAN, C., CHAN, Y., ZHANG, Q., LIN, H., YIP, G. W. K., KUM, L. C. C., KONG, S., ZHANG, Y., et al. (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.03648.x · Cited by 79
“Therefore, the current study was conducted (1) to investigate whether LV reverse remodeling and improvement of systolic function occur after CRT in advanced heart failure patients with mildly prolonged QRS complex duration (>120–150 ms); (2) to determine whether clinical symptoms and exercise capacity improve in these…”
Olshansky, B., Day, J. D., Sullivan, R. M., Yong, P., Galle, E. G., & Steinberg, J. S. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.07.038 · Cited by 78
Mechanism of Decrease in Mitral Regurgitation After Cardiac Resynchronization Therapy
Solı́s, J., McCarty, D., Levine, R. A., Handschumacher, M. D., Fernández‐Friera, L., Chen‐Tournoux, A., Mont, L., Vidal, B., Singh, J. P., Brugada, J., et al. (2009) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.108.823732 · Cited by 78
“Indices of mechanical dyssynchrony calculated included (1) maximal time delay (MTD) defined as the difference between the maximal and minimal times to peak longitudinal systolic velocity among 12 segments, (2) standard deviation of the time to peak longitudinal systolic velocity for all 12 segments evaluated as Ts-SD,…”
Mazurek, J. A., & Jessup, M. L. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.08.001 · Cited by 81
Taylor, R. J., Umar, F., Panting, J. R., Stegemann, B., & Leyva, F. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.10.024 · Cited by 77
Niederer, S., Shetty, A., Plank, G., Bostock, J., Razavi, R., SMITH, N. P., & Rinaldi, C. A. (2011) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2011.03243.x · Cited by 77
“The model predicts that: (1) preexcitation of the LV in regions of slow conduction improves hemodynamic response to CRT, (2) multisite CRT offers moderate improvements in acute hemodynamic response over conventional CRT but that this is the case only in the presence of scar, (3) minimizing QRS duration or activation t…”
MethodRickard, J., Popović, Z., Verhaert, D., Sraow, D. I., Baranowski, B. J., Martin, D. O., Lindsay, B. D., Varma, N., TCHOU, P. J., Grimm, R. A., et al. (2011) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.03022.x · Cited by 77
Noninvasive Imaging in Cardiac Resynchronization Therapy—Part 1: Selection of Patients
Ypenburg, C., Westenberg, J. J. M., Bleeker, G. B., de Veire, N. V., Marsan, N. A., Henneman, M. M., van der Wall, E. E., Schalij, M. J., Abraham, T. P., Barold, S. S., et al. (2008) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.01212.x · Cited by 77
“(1) New York Heart Association (NYHA) class III or IV despite maximal therapy, (2) LV ejection fraction (LVEF) <35%, (3) QRS duration >120 ms.”
BackgroundThe Valsalva Maneuver: A Bedside “Biomarker” for Heart Failure
Felker, G. M., Cuculich, P. S., & Gheorghiade, M. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.059 · Cited by 77
Electrical Remodeling in Cardiac Hypertrophy
Hill, J. A. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2003.08.002 · Cited by 77
“Recent data indicate that biventricular and left ventricular resynchronization pacing therapies favorably remodel ventricular myocardium to reduce cardiovascular mortality and provide significant clinical improvement (Abraham et al. 2002).”
BackgroundErythropoietin as a treatment of anemia in heart failure: Systematic review of randomized trials
Kotecha, D., Ngo, K., Walters, J. A. E., Manzano, L., Palazzuoli, A., & Flather, M. D. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.02.013 · Cited by 77
Auger, D., Höke, U., Bax, J. J., Boersma, E. H., & Delgado, V. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.03.021 · Cited by 77
Blendea, D. C., Shah, R. V., Auricchio, A., Nandigam, V., Orencole, M. P., Heist, E. K., Reddy, V. Y., McPherson, C. A., Ruskin, J. N., & Singh, J. P. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.05.023 · Cited by 77
Women have better long-term prognosis than men after cardiac resynchronization therapy
Zabarovskaja, S., Gadler, F., Braunschweig, F., Ståhlberg, M., Hörnsten, J., Linde, C. M., & Lund, L. H. (2012) · EP Europace · doi:10.1093/europace/eus039 · Cited by 82
Kriekinge, S. D. V., Nishina, H., Ohba, M., Berman, D. S., & Germano, G. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.055160 · Cited by 77
Korean Guidelines for Diagnosis and Management of Chronic Heart Failure
Kim, M., Lee, J., Kim, E. J., Park, D.-G., Park, S., Park, J. J., Shin, M., Yoo, B., Youn, J., Lee, S. E., et al. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0009 · Cited by 80
Lim, P., Donal, E., Lafitte, S., Dérumeaux, G., Habib, G., Réant, P., Thivolet, S., Lellouche, N., Grimm, R. A., & Guéret, P. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr073 · Cited by 76
Metadata
- Authors
- Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Packer, M., Clavell, A. L., Hayes, D. L., Ellestad, M., Trupp, R. J., Underwood, J., Pickering, F., Truex, C., McAtee, P., & Messenger, J.
- Affiliations
- University of Kentucky (US)
- Emory University (US)
- University of Pennsylvania (US)
- Columbia University (US)
- Mayo Clinic (US)
- MemorialCare Long Beach Medical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-06-13
- Volume
- 346
- Issue
- 24
- Pages
- 1845-1853
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2047198412
- Cited by
- 4,648
- References
- 35
- Citations by year
- 2026: 53 · 2025: 74 · 2024: 97 · 2023: 128 · 2022: 96 · 2021: 118 · 2020: 128 · 2019: 116 · 2018: 138 · 2017: 180 · 2016: 176 · 2015: 175 · 2014: 205 · 2013: 215 · 2012: 224
- FWCI
- 157.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- cardiac resynchronization therapy, chronic heart failure, intraventricular conduction delay, QRS duration, ejection fraction, NYHA functional class, 6-minute walk distance, quality of life, hospitalization, implantable cardioverter-defibrillator complications
- MeSH terms
- Aged, Cardiac Pacing, Artificial, Double-Blind Method, Female, Heart Failure, Hospitalization, Humans, Male, Middle Aged, Pacemaker, Artificial, Quality of Life, Stroke Volume, Survival Analysis, Exercise Tolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.